Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer.

Cell Biosci · 2015 · PMC4574027 · PMID 26388988

Europe PMC DOI

hedged sentence

0.3800

closest p · 7.6× alpha

0.3800

boldest claim

The sentences

did not reach statistical significancep = 0.38not close (p > 0.1)

Further evaluation revealed a slightly longer survival of patients without RPN2 alteration, but that did not reach statistical significance (p = 0.38, data not shown).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.